Strategy Asset Managers’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$297K Sell
619
-4
-0.6% -$2.05K 0.05% 217
2025
Q4
$350K Buy
623
+170
+38% +$96.5K 0.06% 188
2025
Q3
$233K Buy
+453
New +$198K 0.04% 236

Other funds holding MEDP

Strategy Asset Managers's MEDP Position: Q1 2026 in Review

Strategy Asset Managers reduced its Medpace (MEDP) stake by 0.64% in Q1 2026, selling an estimated $2.05K and leaving 619 shares worth $297K. The position accounts for 0.05% of the portfolio, ranked #217.

Strategy Asset Managers first reported a position in MEDP in Q3 2025 and has held it in 3 quarters since. The position peaked at $350K in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Strategy Asset Managers held 619 shares of Medpace worth $297K as of Q1 2026.
  • Strategy Asset Managers sold 4 Medpace shares in Q1 2026, an estimated $2.05K.
  • Medpace made up 0.05% of Strategy Asset Managers's portfolio in Q1 2026, its #217 holding.
  • Strategy Asset Managers first reported a position in Medpace in Q3 2025 and has held it in 3 quarters since.
  • Strategy Asset Managers's Medpace position peaked at $350K in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Strategy Asset Managers's 13F filing for Q1 2026, filed 12 May 2026.